Juneyao Grand Healthy DrinksCo.,Ltd. (605388.SS)
Shanghai, CN
Hubei Juneyao Health Drinks Co., Ltd. is dedicated to the full spectrum of activities involved in probiotic beverages, spanning their innovation, manufacturing, commercialization, and distribution. Their product portfolio is extensive, featuring not only drinks enriched with lactic acid bacteria but also various herbal and soothing beverages. These items are marketed under their distinct brand names, such as weiwei, Xiaomengxing, and werdery. This enterprise was established in 1994 and maintains its primary offices in Yichang, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.00% | -0.98% | +9.44% | +2.32% | -9.59% | -4.97% | +13.85% | -25.97% | -66.07% | -63.44% | -63.44% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Beverages - Non-Alcoholic: +4.6%-8.7% Q1'26: +7.3% (vs Q1'25)
-
EPS growth Beverages - Non-Alcoholic: +9.3%-540.0% Q1'26: -26.0% (vs Q1'25)
-
FCF margin FCF growth · Beverages - Non-Alcoholic: +17.3%-12.9% Q1'26: -32.5% (vs Q1'25)
-
EBIT margin Beverages - Non-Alcoholic: +13.6%-20.1% Q1'26: +3.0% (vs Q1'25)
-
ROIC Beverages - Non-Alcoholic: +11.1%-23.3% Q1'26: +3.1% (vs Q1'25)
-
Share dilution Beverages - Non-Alcoholic: +0.1%+2.1% Q1'26: +7.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Beverages - Non-Alcoholic: -0.18×-0.12× Q1'26: 0.58× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|---|
| Revenue |
851.90M
est: 1.00B (-15.0%)
|
913.60M
est: 1.02B (-10.4%)
|
986.10M
est: 1.71B (-42.4%)
|
1.63B
est: 1.51B (+8.5%)
|
1.46B
est: 2.21B (-33.9%)
|
1.33B
est: 2.86B (-53.4%)
|
| EBITDA |
303.18M
est: 151.79M (+99.7%)
|
223.53M
est: 154.51M (+44.7%)
|
121.30M
est: 259.19M (-53.2%)
|
129.20M
est: 228.13M (-43.4%)
|
41.96M
est: 148.60M (-71.8%)
|
-184.52M
est: 192.40M (-195.9%)
|
| EBIT |
285.30M
est: 118.44M (+140.9%)
|
196.46M
est: 120.57M (+62.9%)
|
91.09M
est: 202.25M (-55.0%)
|
85.26M
est: 178.02M (-52.1%)
|
-29.38M
est: 60.93M (-148.2%)
|
-268.03M
est: 78.89M (-439.7%)
|
| Net Income |
213.83M
est: 237.09M (-9.8%)
|
146.99M
est: 216.29M (-32.0%)
|
76.74M
est: 424.27M (-81.9%)
|
57.58M
est: 91.51M (-37.1%)
|
-29.12M
est: 140.10M (-120.8%)
|
-190.20M
est: 186.81M (-201.8%)
|
| SGA |
172.93M
est: 186.91M (-7.5%)
|
244.49M
est: 190.27M (+28.5%)
|
268.58M
est: 319.16M (-15.8%)
|
314.66M
est: 280.92M (+12.0%)
|
386.55M
est: 517.75M (-25.3%)
|
234.92M
est: 670.38M (-65.0%)
|
| EPS |
0.40
est: 0.41 (-1.8%)
|
0.24
est: 0.37 (-35.4%)
|
0.13
est: 0.73 (-82.2%)
|
0.10
est: 0.16 (-36.4%)
|
-0.05
est: 0.24 (-121.2%)
|
-0.32
est: 0.31 (-201.8%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chenchen Wang | Deputy General Manager | — | female |
| Hong Ze Lei | Deputy General Manager | — | male |
| Joy Luo | Deputy GM & Director | — | male |
| Peng Cui | Financial Director | — | male |
| Qin Guo | Secretary to the Board | — | male |
| Wei Yu | GM & Director | — | male |
| Weibing Xiang | Deputy General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 605388.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
